Literature DB >> 7468625

Nosocomial viral hepatitis.

J E Maynard.   

Abstract

Viral hepatitis has long been recognized as a hazard in the health care environment. Nosocomial hepatitis B initially emerged in the setting of transfusion-associated infection and later in patients in dialysis units and on oncology wards. Health care workers are also at risk of acquiring nosocomial hepatitis B and more likely to acquire the infection from their patients than vice versa. Rare instances of nosocomially-transmitted hepatitis A have been documented, but hepatitis A virus excretion patterns in relation to onset of disease generally preclude significant transmission in the hospital setting. With virtual elimination of transfusion-transmitted hepatitis B, non A/non B hepatitis is the most significant cause of post-transfusion hepatitis and may occur in as high as 15 percent of the patients given multiple transfusions. Control of nosocomial viral hepatitis is based on the creation of environmental barriers specific for each viral agent. For hepatitis B, serologic surveillance of staff and patients in high risk areas, together with use of immunoglobulins for post-exposure prophylaxis and hepatitis B vaccine in susceptible persons, promises to significantly reduce nosocomial infection. Isolation procedures for patients admitted with hepatitis A or B are based on use of blood precautions for hepatitis B, modified enteric precautions for hepatitis A and a combination of both for non A/non B or etiologically unspecified hepatitis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7468625     DOI: 10.1016/0002-9343(81)90785-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

1.  PLP fixation for combined routine histology and immunocytochemistry of liver biopsies.

Authors:  F Brenes; S Harris; M O Paz; L M Petrovic; P J Scheuer
Journal:  J Clin Pathol       Date:  1986-04       Impact factor: 3.411

2.  Mucocutaneous injuries at a university teaching hospital.

Authors:  S A McCurdy; T J Ferguson; M B Schenker
Journal:  West J Med       Date:  1989-05

3.  Cost without benefit? The introduction of hepatitis B vaccine in Canada.

Authors:  R A Coates; J G Rankin
Journal:  Can Med Assoc J       Date:  1983-05-15       Impact factor: 8.262

4.  Hepatitis B vaccination programs for health care personnel in U.S. hospitals.

Authors:  P G Alexander; R Johnson; W W Williams; S C Hadler; J W White; P J Coleman
Journal:  Public Health Rep       Date:  1990 Nov-Dec       Impact factor: 2.792

5.  What is the dentist's occupational risk of becoming infected with hepatitis B or the human immunodeficiency virus?

Authors:  E I Capilouto; M C Weinstein; D Hemenway; D Cotton
Journal:  Am J Public Health       Date:  1992-04       Impact factor: 9.308

6.  Hepatitis B vaccine requirements in at-risk hospital personnel: a survey of hospitals in Metropolitan Toronto.

Authors:  R A Coates; J Rankin; M L Halliday
Journal:  Can Med Assoc J       Date:  1983-03-01       Impact factor: 8.262

7.  Infectivity of medical staff for hepatitis B.

Authors:  H Hofmann; W Tuma; F X Heinz; W Frisch-Niggemeyer; C Kunz
Journal:  Infection       Date:  1988 May-Jun       Impact factor: 3.553

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.